SUBSCRIBE
SUBSCRIBE

Hexagon Bio

NEWS
BioMidwest
Money on the Move: September 22 – 28
These life sciences companies are falling into some cold, hard investment cash.
September 29, 2021
 · 
4 min read
 · 
Kate Goodwin
Biotech Bay
GenEdit Uncloaks to Solve Gene Editing “Delivery Problem”
Kunwoo Lee has uncloaked his solution to the gene-editing “delivery problem” with $26 million in Series A funds for his company, GenEdit.
September 23, 2021
 · 
3 min read
 · 
Kate Goodwin
Look at these top life science startups.
Pharm Country
Top Life Science Startups to Watch in 2021
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life science startups in North America that recently launched.
January 5, 2021
 · 
16 min read
 · 
Mark Terry
Biotech Bay
Hexagon Bio to Move into Clinic with $47 Million in Series A Financing
Hexagon Bio, a California-based biotechnology company turning nature’s DNA into medicines for cancers and infectious diseases with unmet needs, will move into clinical research with $47 million in Series A financing.
September 16, 2020
 · 
2 min read
 · 
Heather McKenzie
AWARDS
  • NextGen Class of 2021
JOBS
IN THE PRESS
Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived Small Molecules
February 14, 2023
 · 
5 min read
Biotech Bay
Hexagon Bio Raises $61 Million to Advance Novel Small-Molecule Medicines Mined from Microbial Genomes
September 22, 2021
 · 
3 min read